國家衛生研究院 NHRI:Item 3990099045/15386
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 856877      在线人数 : 951
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于NHRI管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/15386


    题名: TASL-TSOC Taiwan position statement for the management of metabolic dysfunction-associated fatty liver disease and cardiovascular diseases
    作者: Cheng, PN;Chen, WJ;Hou, CJ;Lin, CL;Chang, ML;Wang, CC;Chang, WT;Wang, CY;Lin, CY;Hung, CL;Peng, CY;Yu, ML;Chao, TH;Huang, JF;Huang, YH;Chen, CY;Chiang, CE;Lin, HC;Li, YH;Lin, TH;Kao, CH;Wang, TD;Liu, PY;Wu, YW;Liu, CJ
    贡献者: Institute of Cellular and Systems Medicine
    摘要: Metabolic dysfunction associated fatty liver disease (MAFLD) is an increasingly important and common liver disease worldwide. The diagnosis of MAFLD is based on the presence of steatosis on image/histology/serum markers accompanied with presence of at least one of the three metabolic features that include overweight/obesity, type II diabetes mellitus, and metabolic risk factors. MAFLD is not only a liver disease but also a contributing or related factor of cardiovascular diseases (CVD) which lead to the major etiology of morbidity and mortality in patients with MAFLD. Hence, understanding the association of MAFLD and CVD, surveillance and risk stratification of MAFLD in patients with CVD, and current status of management of MAFLD are urgently needed for both hepatologist and cardiologist. The purpose of this Taiwan position statement is to review literature and provide suggestions that cover from epidemiology, etiology, risk factors, risk stratification, non-pharmacological intervention, and potential drug treatment of MAFLD, especially focusing on association with CVD.
    日期: 2024-01
    關聯: Clinical and Molecular Hepatology. 2024 Jan;30(1):16-36.
    Link to: http://dx.doi.org/10.3350/cmh.2023.0315
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2287-2728&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001186681200009
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85181726040
    显示于类别:[王朝永] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    PUB37793641.pdf1511KbAdobe PDF106检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈